Repligen Corporation is a company publicly traded on the NASDAQ Stock Market under the symbol RGEN. The company’s main activity sector is Health Care, sub-industry Biotechnology: Biological Products (No Diagnostic Substances). Repligen Corporation IPO year (Initial Public Offering – when its stocks were launched for trading) is 1986.
Below are the latest details regarding the Repligen Corporation trading on NASDAQ, like the stock price, change since previous trading date:Unfortunately, we could not get stock quote RGEN this time.
Repligen Corporation is only one of the many companies listed on the NASDAQ market. To trade Repligen Corporation shares, you need to get a contract with a broker – either an online broker or a company you know, like your bank. Some FX/Binary brokers also offer different stocks in their trading platform as CFDs. With these CFDs you do not own the stock, but rather leverage a position as to weather this stock will go up or down in a set interval. Please note that while CFDs can bring great winnings with limited capital, they also carry a high risk of losing all capital. Repligen Corporation (RGEN) stock trading at these CFD brokers is not guaranteed as each broker has a different list of stocks in their trading bucket.